Skip to main content

Table 1 Health technologies (interventions)

From: Determining optimal strategies for primary prevention of cardiovascular disease: systematic review, cost-effectiveness review and network meta-analysis protocol

Pharmacologic interventions

Lipid lowering medications

Blood pressure lowering medications

Nutritional supplements

Others

Atorvastatin

Fluvastatin

Lovastatin

Pitavastatin

Pravastatin

Rosuvastatin

Fenofibrate

Bezafibrate

Ezetimibe

ACE inhibitors

Angiotensin receptor blockers (ARBs)

Calcium channel blockers

Thiazide diuretics

Adrenergic receptor antagonists (alpha and beta blockers)

Vasodilators

Renin inhibitors

Vitamin D, E, K and multivitamins

Niacin

Omega 3 and fatty acids

Anti-oxidants

Calcium

Co-enzyme Q10

Selenium

Folic acid

Garlic

Fixed dose combinations

‘polypill’

Antiplatelet agent (Aspirin)

Lifestyle-modification interventions

Dietary interventions

Health promotion

Exercise/physical activity in general

 

Mediterranean diet

Fibres

Nut consumption

Chocolate

Fruits and vegetables

Green and black tea

Reduced salt intake

Reduced fat intake

Smoking cessation

Weight reduction

Reduction in alcohol intake

Multiple risk factors intervention

Digital health promotion

Endurance (or aerobic) exercise

Strengthening exercise

Balance

Tai-chi

Flexibility

Yoga

Aquatic

Qiqong

Transcendental meditation

Combined exercise

 

Structural and policy-based interventions (population-wide interventions)

Taxation and subsidies

Mass media campaigns

Food and menu labelling

Local food environment

Worksite wellness programmes

Marketing restrictions

Quality standards

Healthy local environment

Addressing air pollution